The relative impact and future burden of prostate cancer in the United States Article Conference Paper uri icon

Overview

MeSH Major

  • Fluorodeoxyglucose F18
  • HSP90 Heat-Shock Proteins
  • Positron-Emission Tomography
  • Receptor, ErbB-2

abstract

  • The overall decrease in the mortality rate of prostate cancer since 1994 may be due to improvements in screening, diagnosis and treatments. Despite the decreasing mortality rate the aging of the American population and the exponential increase in prostate cancer incidence and mortality rates by age are important to consider when assessing the future morbidity and mortality burden of this disease and the appropriate allocation of health care resources.

publication date

  • November 2004

Research

keywords

  • Conference Paper

Identity

Digital Object Identifier (DOI)

  • 10.1097/01.ju.0000142068.66876.53

PubMed ID

  • 15535436

Additional Document Info

start page

  • S13

end page

  • 6; discussion S17

volume

  • 172

number

  • 5 II